The Economics of Drug Development: What it Will Really Take to Reduce Drug Prices
Orr Inbar, CEO and co-founder of QuantHealth, unpacks the growing frustration over drug prices and the misperceptions fueling distrust in the pharmaceutical industry. With clinical trials now more expensive and less successful than ever, Inbar explores how A.I.-powered simulations can fundamentally change the economics of drug development, reducing development costs, boosting approval rates and ultimately bringing more affordable treatments to market.
